12:00 AM
 | 
Mar 22, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ergo regulatory update

ERGO said it will appeal the non-approvable letter it received from the FDA's Division of Metabolic and...

Read the full 61 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >